Innovating Works
SMARTER: Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies a... ACHILLES THERAPEUTICS UK LIMITED participó en un HORIZON EUROPE: HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 Autologous immunotherapies have revolutionised cancer treatment providing impressive survival benefits in patients with blood cancers. The n...
2022-06-27 - 2025-08-31 | Financiado
DECOD-Ag: Revolutionary Platform to Decipher Immunogenicity of Tumour Neoantigens the Ultimate Targets for Fu... ACHILLES THERAPEUTICS UK LIMITED participó en un H2020: H2020-FETOPEN-2018-2020 Immunotherapy has revolutionised cancer treatment, providing survival benefits in patients with hard-to-treat tumours. Tragically, these ben...
2021-03-08 - 2026-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.